Hong Kong Professional Services Stock News

SEHK:3692
SEHK:3692Pharmaceuticals

Hansoh Pharmaceutical Group’s Valuation After HS-10541 Clinical Trial Approval For KRAS G12C Tumors

Hansoh Pharmaceutical Group (SEHK:3692) has drawn fresh investor attention after announcing that its self developed Class 1 drug candidate HS-10541 received clinical trial approval in China for KRAS G12C mutated advanced solid tumors. See our latest analysis for Hansoh Pharmaceutical Group. The HS-10541 trial approval comes as Hansoh Pharmaceutical Group's share price has softened recently, with a 30 day share price return down 13.62%, even while the 1 year total shareholder return stands at...
SEHK:9660
SEHK:9660Software

Asian Growth Companies With High Insider Ownership In May 2026

As the Asian markets navigate a complex landscape of geopolitical tensions and economic uncertainties, investors are increasingly focused on companies with strong growth potential and significant insider ownership. In this environment, stocks that combine robust internal backing with promising expansion prospects can offer a compelling investment narrative.
SEHK:862
SEHK:862IT

Xtep International Holdings And 2 Other Asian Penny Stocks Worth Watching

As global markets navigate a complex landscape marked by inflation concerns and geopolitical tensions, the Asian market remains a focal point for investors seeking opportunities in emerging sectors. Penny stocks, though an older term, continue to represent smaller or less-established companies that can offer significant value and growth potential. By focusing on those with robust financials and clear growth trajectories, investors might uncover promising opportunities among these lesser-known...
SEHK:2600
SEHK:2600Metals and Mining

A Look At Aluminum Corporation of China (SEHK:2600) Valuation After EV Demand Fuels Talk Of A Technical Rebound

Electric vehicle demand and technical rebound thesis Recent analyst commentary on Aluminum Corporation of China (SEHK:2600) discusses a potential technical rebound, connecting current interest in the stock to aluminum demand associated with the expanding electric vehicle industry. See our latest analysis for Aluminum Corporation of China. At the latest share price of HK$11.88, the stock has seen a sharp 1-day share price return of 9.29% and 7-day share price return of 14.56%, even though the...
SEHK:9885
SEHK:9885Healthcare

Nickel Asia And 2 Other Penny Stocks Making Waves In Global

Amidst a backdrop of rising inflation worries and fluctuating consumer sentiment, global markets have shown resilience, with major U.S. stock indexes reaching new highs and small-cap stocks outperforming their larger peers. In such a dynamic market landscape, investors often look beyond the well-trodden paths to discover potential in lesser-known areas like penny stocks. While the term "penny stocks" might seem outdated, these smaller or newer companies can offer unique growth opportunities...
SEHK:1093
SEHK:1093Pharmaceuticals

Assessing CSPC Pharmaceutical Group (SEHK:1093) Valuation After New Autoimmune And Nephrology Drug Approvals

CSPC Pharmaceutical Group (SEHK:1093) has recently secured Chinese approvals for Enyike, a ustekinumab biosimilar, and 4mg budesonide enteric-coated capsules, broadening its autoimmune and nephrology treatment offerings for patients. See our latest analysis for CSPC Pharmaceutical Group. At a latest share price of HK$7.69, the stock has seen a 1-day share price return of 4.77% and a 7-day share price return of 1.45%, but a 90-day share price return that is down 23.56%. The 1-year total...
SEHK:2142
SEHK:2142Biotechs

HBM Holdings (SEHK:2142) Valuation Check After Positive LET003 Obesity Antibody Preclinical Data

HBM Holdings (SEHK:2142) is in focus after Harbour BioMed reported preclinical data for LET003, an ACVR2A/2B-targeting antibody developed using its AI-based Hu-mAtrIx platform, showing superior pharmacokinetics compared with several competitors. See our latest analysis for HBM Holdings. At a share price of HK$12.15, HBM Holdings has seen the 30 day share price return fall 13.21%, even as the 1 year total shareholder return is 37.91% and the 3 year total shareholder return is very large. This...
SEHK:836
SEHK:836Renewable Energy

A Look At China Resources Power Holdings (SEHK:836) Valuation After Strong Photovoltaic Generation Growth In 2026

Why the latest operating data matters for investors China Resources Power Holdings (SEHK:836) has reported new operating figures for April and the first four months of 2026, with higher total net generation supported by strong photovoltaic output, which offset weaker wind generation. See our latest analysis for China Resources Power Holdings. At a share price of HK$20.18, the stock has built clear positive momentum, with a 90-day share price return of 10.27% and a 5-year total shareholder...
SEHK:797
SEHK:797Entertainment

Global Penny Stocks To Watch In May 2026

Amid a backdrop of rising inflation concerns and geopolitical tensions, major U.S. stock indexes have reached new heights, driven by enthusiasm around artificial intelligence stocks and positive earnings reports. As the market landscape continues to evolve, investors might find opportunities in areas often overlooked by mainstream attention. Penny stocks, though sometimes seen as relics of past speculative trends, remain relevant for those seeking growth potential in smaller or newer...
SEHK:2386
SEHK:2386Construction

A Look At SINOPEC Engineering (Group) (SEHK:2386) Valuation After Chairman Jiang Dejun’s Resignation

SINOPEC Engineering (Group) (SEHK:2386) is in focus after Chairman and executive director Mr. JIANG Dejun resigned, stepping down from several key board committees. The company cited age and noted there were no disagreements. See our latest analysis for SINOPEC Engineering (Group). The share price has fallen around 25% over the past three months and is down about 25% year to date, even though the 3 year total shareholder return is about 101%. This means recent momentum appears weaker than the...
SEHK:2616
SEHK:2616Biotechs

A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Pralsetinib’s First Domestic Launch In China

CStone Pharmaceuticals (SEHK:2616) has announced the first domestically produced batch of pralsetinib capsules in China, starting nationwide distribution and leveraging National Reimbursement Drug List inclusion alongside significant year-on-year sales growth. See our latest analysis for CStone Pharmaceuticals. The latest product news comes after a strong run in CStone Pharmaceuticals’ stock, with the share price at HK$8.02 and a year-to-date share price return of 50.19%. The 1-year total...
SEHK:2442
SEHK:2442Construction

A Look At Easy Smart Group Holdings (SEHK:2442) Valuation After New Chairman Appointment

Easy Smart Group Holdings (SEHK:2442) has drawn fresh attention after appointing Dr. Tang Tian Shen as executive director, chairman and nomination committee member, while current chief executive Mr. Ng Wing Woon Dave remains in his role. See our latest analysis for Easy Smart Group Holdings. Despite the leadership change, the stock has been volatile, with a 90 day share price return of 176.67% but a 30 day share price return down 12.72%. At the same time, the 1 year total shareholder return...
SEHK:1050
SEHK:1050Electronic

Asian Penny Stocks To Watch In May 2026

As global markets navigate a complex landscape of inflation concerns and geopolitical tensions, Asian equities have shown resilience with varying performances across major indices. In this context, penny stocks—though an older term—remain a notable area of interest for investors seeking opportunities in smaller or emerging companies. By focusing on those with strong financial foundations, these stocks can offer potential value and stability amidst the broader market dynamics.
SEHK:3800
SEHK:3800Semiconductor

Assessing GCL Technology Holdings (SEHK:3800) Valuation After Sharp Revenue And Earnings Deterioration

Recent figures for GCL Technology Holdings (SEHK:3800) show a 55% year-over-year revenue contraction and a 289% decline in net income, with negative cash flows and sector headwinds prompting a cautious analyst stance. See our latest analysis for GCL Technology Holdings. At a share price of HK$0.82, the stock has seen short term pressure, with a 30 day share price return down 18% and a 90 day return down 33.33%, while the 3 year total shareholder return is down 53.42%. This suggests that...
SEHK:9999
SEHK:9999Entertainment

Should NetEase’s Extended US$5B Buyback And Dividend Plan Require Action From NetEase (SEHK:9999) Investors?

NetEase has already reported first-quarter 2026 results showing year-over-year growth in revenue and net income, while also approving a US$0.144 per-share dividend for the quarter and completing US$2.10 billion of buybacks under its November 2022 program. Alongside extending its up to US$5.00 billion repurchase authorization through January 2029, the company’s steady earnings expansion underlines its emphasis on returning capital to shareholders. We’ll now examine how NetEase’s combination...
SEHK:293
SEHK:293Airlines

Will Board Overhaul And Guy Bradley’s Appointment Change Cathay Pacific Airways' (SEHK:293) Narrative

At its annual general meeting on 13 May 2026, Cathay Pacific Airways’ shareholders approved amendments to the company’s Articles of Association and endorsed sweeping changes to the board, including the retirement of Chair Patrick Healy and the appointment of Guy Martin Coutts Bradley as Executive Director and Chair. The reshaped board, which brings in senior figures from Swire and Air China, could meaningfully influence Cathay Pacific’s governance priorities, international partnerships, and...
SEHK:6980
SEHK:6980Food

Asian Undervalued Small Caps With Insider Action In May 2026

As Asian markets navigate a complex landscape of geopolitical tensions and economic challenges, small-cap stocks have shown resilience, with value-oriented shares outperforming their larger counterparts. Amid this backdrop, identifying promising investment opportunities involves considering factors such as market positioning and insider activity, which can signal confidence in a company's potential amid broader market fluctuations.